company

STABEKK APOTEK AS

1369 STABEKK

Return on Equity
164,29 %
Current Ratio
1,38
Debt-to-Equity Ratio
7,79
Key figures (NOK)2022
Revenue11 725 000
Net Income115 000
Total Assets1 983 000
Total Equity70 000
Income (NOK)2022
Revenue11 725 000
Expenditure11 551 000
Operating Profit175 000
Financial Income1 000
Financial Costs1 000
Financial Balance0
Earnings Before Tax175 000
Tax61 000
Net Income115 000
Balance (NOK)2022
Total Fixed Assets103 000
Total Current Assets1 880 000
Total Assets1 983 000
Total Retained Equity40 000
Total Equity70 000
Total Long-Term Debt545 000
Total Current Debt1 367 000
Total Equity and Debt1 983 000
Cash flow (NOK)2022
Sales Income11 725 000
Other Income0
Revenue11 725 000
Cost of Goods Sold8 762 000
Salary Costs1 565 000
Depreciation26 000
Impairment0
Expenditure11 551 000
Operating Profit175 000
Financial Income1 000
Financial Costs1 000
Financial Balance0
Dividends0
Net Income115 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures85 000
Total Tangible Assets85 000
Total Fiancial Fixed Assets18 000
Total Fixed Assets103 000
Stock1 195 000
Total Investments0
Cash, Bank227 000
Total Current Assets1 880 000
Total Assets1 983 000
Total Equity70 000
Short-Term Group Debt95 000
Total Long-Term Debt545 000
Creditors995 000
Unpaid Taxes103 000
Dividends0
Other Current Debt135 000
Total Current Debt1 367 000
Total Equity and Debt1 983 000
Financial indicators2022
Return on Equity164,29 %
Debt-to-Equity Ratio7,79
Operating Profit Margin1,49 %
Current Ratio1,38
Quick Ratio10,93
Equity Ratio0,04
Gross Profit Margin25,27 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English